However, I think that connection [manufacturing in China?]might make infringement difficult to prove, i.e. how can MNTA prove infringement done by Amphastar Nanjing Pharma?
Unlikely since they will have had to be transparent with the FDA - so at the very least a subpoena to the FDA would produce the answer.